Mayo Clinic

Morie Gertz, MD

Position
Professor of Medicine

Research Focus
 Morie Gertz, M.D., has research interests in amyloidosis and multiple myeloma. Particularly, Dr. Morie Gertz studies relapse rates in patients with multiple myeloma and amyloidosis when being treate... Read More

S. Vincent Rajkumar, MD

Position
Chair, ECOG Myeloma Committee, Chair, Mayo Clinic Myeloma Amyloidosis Dysproteinemia Group

Research Focus
Dr. S. Vincent Rajkumar, MD is engaged in clinical, epidemiological and laboratory research in myeloma and related disorders. I ha... Read More

Shaji Kumar, MD

Position
Professor of Medicine; Consultant in the Division of Hematology, Internal Medicine

Research Focus
The research of Dr. Shaji Kumar, MD, focuses on development of novel drugs for treatment of myeloma.Dr. Shaji Kumar's research team evalu... Read More

Angela Dispenzieri, MD

Position
Professor of Medicine, Professor of Laboratory Medicine And Pathology

Research Focus
Dr. Angela Dispenzieri, MD, conducts research in plasma cell disorders, including multiple myeloma, amyloidosis, POEMS syndrome and other rare plasma c... Read More

Martha Q. Lacy, MD

Position
Dr. Martha Q. Lacy, MD is Chair of Hematology and Professor of Medicine at the Mayo Clinic Rochester. Her areas of research include clinical trials, immunomodulation and virotherapy for myeloma. Research: As a member of Mayo Clinic's Myeloma, Amyloidosis, Dysproteinemia Group, Martha Q. Lacy, M.D.... Read More

Stephen Russell, MD, PHD

Position
Professor of Medicine

Research Focus
The research interests of Dr. Stephen Russell, MD, PhD, center on demonstrating the value of oncolytic virotherapy as a new modality for the treatment of cancer. Viruses from several families are engi... Read More

Francis K. Buadi, MD

Position
Hematologist, Assistant Professor of Medicine

Research Focus
Plasma cell disorder Stem cell transplantation Amyloidosis ... Read More

Matthew T. Drake, MD, PHD

Position
Associate Professor of Medicine

Research Focus
Monoclonal gammopathy bone disease. Dr. Matthew T. Drake is the program director and principal investigator (PI) on a study focused on the origins and development of monoclonal gammopathy ... Read More

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
AmazonSmile
 

Thanks to our site sponsors:

Takeda Oncology Celgene Adaptive biotechnologies